Internal Medicine, Pulmonary Disease · Saint Louis, MO
NPI
1003895236
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
11200 Tesson Ferry Rd, Suite 100
Saint Louis, MO, 63123
Phone (314) 849-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
1,740 services
Medicare patients, 2024
903
Average age 73
Drug cost, 2024
$1.2M
3,712 prescriptions
Company payments, 2025
$63K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph M Ojile was code 99213 (office e&m - established), 668 times for 579 patients. In total Joseph M Ojile billed 1,740 services in 15 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 668 | 579 | $61.52 | $41K |
| 99214 Office E&M - Established | Office | 276 | 198 | $87.87 | $24K |
| 95806 Sleep Study | Office | 151 | 145 | $31.18 | $4,709 |
| 94726 Pulmonary Function Testing | Office | 102 | 96 | $39.50 | $4,029 |
| 94060 Pulmonary Function Testing | Office | 101 | 96 | $26.27 | $2,653 |
| 94729 Pulmonary Function Testing | Office | 100 | 95 | $40.69 | $4,069 |
| 94640 Treatment - Miscellaneous | Office | 98 | 94 | $5.51 | $540 |
| 95811 Sleep Study | Office | 70 | 64 | $93.47 | $6,543 |
| 99204 Office E&M - New | Office | 53 | 53 | $112.74 | $5,975 |
| 99203 Office E&M - New | Office | 48 | 48 | $68.91 | $3,308 |
| 95810 Sleep Study | Office | 34 | 34 | $87.31 | $2,969 |
| 99205 Office E&M - New | Office | 17 | 17 | $145.36 | $2,471 |
| 99215 Office E&M - Established | Office | 17 | 13 | $109.27 | $1,858 |
By year: 2022 $95K for 1,503 services; 2023 $112K for 1,869 services; 2024 $105K for 1,740 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph M Ojile prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 638 prescriptions and refills. In total Joseph M Ojile wrote 3,712 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 638 | 750 | 114 | $476K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 488 | 605 | 146 | $12K |
| Zolpidem Tartrate Generic | 206 | 268 | 29 | $1,473 |
| Breo Ellipta Fluticasone/Vilanterol | 156 | 192 | 28 | $76K |
| Montelukast Sodium Generic | 151 | 355 | 35 | $1,579 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 135 | 179 | 30 | $112K |
| Prednisone Generic | 120 | 128 | 60 | $400 |
| Clonazepam Generic | 108 | 138 | 14 | $937 |
| Trazodone Hcl Generic | 103 | 167 | 20 | $373 |
| Gabapentin Generic | 84 | 98 | 18 | $647 |
| Alprazolam Generic | 79 | 91 | 12 | $371 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 78 | 85 | Under 11 | $39K |
| Azithromycin Generic | 72 | 72 | 39 | $376 |
| Armodafinil Generic | 64 | 72 | 11 | $3,068 |
| Arnuity Ellipta Fluticasone Furoate | 63 | 83 | 13 | $18K |
Brand drugs: 1,643 claims; generic drugs: 2,069 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph M Ojile $63K ($63K in general payments such as food, travel and fees) from 25 companies. The largest payer was Fisher & Paykel Healthcare Limited with $36K.
| Company | Payments | Amount |
|---|---|---|
| Fisher & Paykel Healthcare Limited FPH.NZ | 7 | $36K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 13 | $11K |
| Eli Lilly and Company LLY | 5 | $8,527 |
| Axsome Therapeutics, Inc. AXSM | 14 | $3,704 |
| Fisher & Paykel Healthcare Inc FPH.NZ | 2 | $438 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $365 |
| Harmony Biosciences LLC HRMY | 13 | $341 |
| GlaxoSmithKline, LLC. GSK | 18 | $229 |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $209 |
| Verona Pharma, Inc. VRNA | 14 | $188 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.